DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wish to advise that both suppliers are experiencing a supply interruption for capecitabine 500mg tablets as follows: Xelabine Capecitabine 500mg ARTG 213045 Capecitabine Sandoz Capecitabine 500mg ARTG 201800 This supply interruption is…
Read more
HPS Pharmacies wish to advise that Pharmaco Australia is experiencing a supply interruption for Zyprexa® IM as follows: Zyprexa IM® Vial Olanzapine 10mg ARTG 76867 This supply interruption is expected to be…
Read more
HPS Pharmacies wish to advise that all suppliers are experiencing a supply interruption for prazosin 1mg and 2mg tablets, as follows: Product ARTG Estimated return date APO-Prazosin 1 mg 73858 End-August 2025 APO-Prazosin 2…
Read more
HPS Pharmacies wish to advise that Fresenius Kabi has placed restrictions on the ordering of their paracetamol vials, as follows: Paracetamol Kabi 1g/100mL Vials Paracetamol 1g/100mL ARTG 203624 Fresenius Kabi has advised that stock…
Read more
HPS Pharmacies wishes to advise that Pfizer is discontinuing their sodium chloride 100 mL vials as follows: Pfizer Sodium Chloride 0.9% IV infusion Sodium Chloride 900mg/100mL ARTG 49280 Pfizer estimates that wholesale stock will…
Read more
HPS Pharmacies wish to advise that Novo Nordisk has released a new presentation of Ozempic®, as follows: Ozempic® 0.25/0.5mg Pen Semaglutide 0.68 mg/mL, 3 mL ARTG 446290 This new product replaces the Ozempic® 0.25/0.5mg…
Read more
